Natera, Inc.
Clinical trials sponsored by Natera, Inc., explained in plain language.
A genetic testing company specializing in prenatal and oncology diagnostics.
Trade on eToro (ad)Not investment advice. Company information is shown for context only. Clinical trials frequently fail.
-
Blood test may let cancer patients take safe breaks from immunotherapy
Disease control Not yet recruitingThis trial investigates whether a sensitive blood test (Signatera) can detect when it is safe to pause immunotherapy in people with advanced solid tumors like lung cancer, melanoma, and colorectal cancer. Participants are randomly assigned to either continuous standard immunother…
Phase: NA • Sponsor: Natera, Inc. • Aim: Disease control
Last updated Aug 06, 2026 00:00 UTC
-
Blood test may take the guesswork out of transplant drug dosing
Disease control Not yet recruitingThis trial tests whether a blood test called Prospera can help doctors better adjust anti-rejection medications in people who have recently received a kidney transplant. The test measures DNA from the donor kidney to spot early signs of rejection or over-suppression. Researchers …
Phase: NA • Sponsor: Natera, Inc. • Aim: Disease control
Last updated Jul 24, 2026 00:00 UTC
-
Blood test may spare some women from radiation after endometrial cancer surgery
Knowledge-focused Not yet recruitingThis study looks at whether a blood test that detects tumor DNA can help decide if women with early-stage endometrial cancer need radiation after surgery. About 1,010 women will be followed for two years. Those with a negative blood test may safely skip radiation, while others re…
Phase: NA • Sponsor: Natera, Inc. • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:00 UTC
-
Blood test may let some stomach cancer patients skip harsh chemo
Knowledge-focused Not yet recruitingThis study tests whether a personalized blood test (Signatera) can identify gastric cancer patients who, after surgery, have no detectable cancer DNA and can safely receive a milder immunotherapy (durvalumab) instead of standard chemotherapy. About 1000 adults with stage II-IVa g…
Phase: NA • Sponsor: Natera, Inc. • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:29 UTC